Evidence map›Paper›PMID 42437890›Full record

ArticleBMC geriatrics2026

Feasibility and short-term outcomes of curative esophagectomy in octogenarian patients with esophageal cancer: a real-world retrospective study.

Binwen Xu, Jie Xiong, Junxu Xiang, Mingpeng Yi, Tao Luo, Hanxiao Wang, Xingqiang Ran, Junhong Liu, Guidong Shi, Maoyong Fu

Abstract read
In one paragraph

Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Binwen Xu *Department of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, No. 1, Maoyuan South Road, Nanchong, Sichuan, 637000, People's Republic of China.
Jie Xiong *Department of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, No. 1, Maoyuan South Road, Nanchong, Sichuan, 637000, People's Republic of China.
Junxu XiangDepartment of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, No. 1, Maoyuan South Road, Nanchong, Sichuan, 637000, People's Republic of China.
Mingpeng YiDepartment of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, No. 1, Maoyuan South Road, Nanchong, Sichuan, 637000, People's Republic of China.
Tao LuoDepartment of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, No. 1, Maoyuan South Road, Nanchong, Sichuan, 637000, People's Republic of China.
Hanxiao WangDepartment of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, No. 1, Maoyuan South Road, Nanchong, Sichuan, 637000, People's Republic of China.
Xingqiang RanDepartment of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, No. 1, Maoyuan South Road, Nanchong, Sichuan, 637000, People's Republic of China.
Junhong LiuDepartment of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, No. 1, Maoyuan South Road, Nanchong, Sichuan, 637000, People's Republic of China.
Guidong ShiDepartment of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, No. 1, Maoyuan South Road, Nanchong, Sichuan, 637000, People's Republic of China.
Maoyong FuDepartment of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, No. 1, Maoyuan South Road, Nanchong, Sichuan, 637000, People's Republic of China. fumaoyongmd@163.com.

Funding

Nanchong City University Science and Technology Strategic Cooperation Special Fund 22SXQT0095Scientific Research Foundation for Advanced Talents, Affiliated Hospital of North Sichuan Medical College 2023GC006
6 · The paper itself

Abstract

backgroundThe role of surgical treatment in patients aged ≥ 80 years with esophageal cancer remains controversial, and real-world evidence remains scarce. This study aimed to evaluate the perioperative safety and mid-term survival outcomes of octogenarian patients following radical esophagectomy.

methodsThis single-center retrospective cohort study consecutively enrolled patients aged ≥ 80 years who underwent radical esophagectomy at our institution between 2020 and 2025. Data on baseline characteristics, perioperative complications, 30-day and 90-day postoperative mortality, overall survival (OS), and disease-free survival (DFS) were collected. Multivariable logistic and Cox regression analyses were performed to identify independent prognostic factors.

resultsA total of 110 patients were included, with a mean age of 81.8 years; 67.3% were male, and 58.2% had COPD. The most common postoperative complications were pulmonary infection (49.1%) and arrhythmia (42.7%); 16 patients (14.5%) required transfer to the ICU because of severe complications. The perioperative mortality rate was 9.1% (10/110). The 90-day postoperative mortality rate was 13.6%. Multivariable logistic regression analysis demonstrated that higher BMI was a protective factor against 90-day mortality. After a median follow-up of 20 months, the 1-year and 2-year OS rates were 81% and 56%, respectively. Multivariable Cox regression analysis indicated that age was the only independent predictor of overall survival (HR, 1.22).

conclusionCurative esophagectomy may remain feasible in carefully selected octogenarian patients, although perioperative morbidity and mortality remain substantial; therefore, treatment decisions should be based on comprehensive multidisciplinary evaluation rather than age alone.

Indexed as

Esophageal NeoplasmsEsophagectomyPostoperative ComplicationsAged, 80 and overFeasibility StudiesFemaleHumansMaleRetrospective StudiesSurvival RateTreatment OutcomeDisease free survivalEsophageal cancerOctogenarian patientsOverall survivalPostoperative complications

Identifiers

PMID42437890
PMCPMC13647635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.